Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Shilpa Medicare is a pharmaceutical company focused on oncology, manufacturing active pharmaceutical ingredients and finished formulations for cancer therapies, and has diversified into non-oncology APIs, transdermal/oral film formulations and biologics (including biosimilar development and CDMO capacity). Revenue is driven by API exports, formulation supplies to regulated and emerging markets, and licensing/CDMO arrangements.
It is among the established Indian players in oncology APIs.
Shilpa Medicare Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Shilpa Medicare Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
Per-share figures are not restated. Shares outstanding changed from 9.78 crore to 19.56 crore in FY26, consistent with a bonus issue or stock split. Each year's EPS and book value below are as that year was filed, on that year's share count — so the per-share line falls across FY26 even where profit did not. Compare the absolute figures (EBITDA, free cash flow, total debt) and the margins across that boundary, not the per-share ones.
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 12.44 | 8.04 | 3.67 |
| Book value / share (₹) | 132.47 | 241.71 | 207.36 |
| Return on equity | 9.4% | 3.3% | 1.8% |
| Return on capital employed | 11.0% | 7.7% | 5.7% |
| Operating margin | 20.5% | 15.9% | 11.9% |
| Net margin | 15.8% | 6.1% | 2.8% |
| EBITDA | ₹435 Cr | ₹317 Cr | ₹244 Cr |
| Free cash flow | ₹-28 Cr | ₹-111 Cr | ₹-49 Cr |
| Total debt | ₹658 Cr | ₹586 Cr | ₹936 Cr |
| Debt to equity | 0.25 | 0.25 | 0.52 |
| Interest coverage | 5.4 | 2.7 | 1.5 |
| Current ratio | 1.31 | 1.46 | 1.26 |
| Shares outstanding | 19,56,00,000 | 9,77,91,000 | 8,68,02,000 |
Open the full income statement, balance sheet and cash flow for SHILPAMED →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.